Predictive oncology regains compliance with nasdaq’s minimum bid price requirement

Predictive oncology inc. announced that based on a notification letter recently received from the listing qualifications department of the nasdaq stock market inc., the company has regained compliance with the minimum bid price requirement set forth in rule 5550(a)(2) of the nasdaq listing rules. on november 16, 2018, the company received a notification letter from the nasdaq indicating that the closing bid price per share had been below $1.00 for a period of 30 consecutive business days and that the company did not meet the minimum price bid requirement. according to the notification letter on deficiency, if at any time during the compliance period, the closing bid price for the company is at least $1.00 for a minimum of 10 consecutive business days, nasdaq will provide the company a written confirmation of compliance and the matter will be closed.
POAI Ratings Summary
POAI Quant Ranking